ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

Iressa May Benefit Some Breast Cancer, Studies Find

December 27, 2002

Chart of FY 1991 Budget For NCI By Mechanism

February 2, 1990

Bristol-Myers Survey Predicts Year 2000 Survival of 66%

April 3, 1987

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009